Doctors who perform in vitro fertilization typically rely on a visual assessment of the embryos when deciding which ones to transfer into the uterus, but two-thirds of such embryos fail to implant. A new test analyzes the proteins and small-molecule metabolites in the fluid surrounding each embryo and compares the resulting metabolic profile with that of a healthy embryo. The test improves implantation rates up to 30 percent. That means doctors can transfer fewer embryos, reducing the chances of an undesired multiple pregnancy.
Courtesy of Molecular Biometrics
Cost: $30,000 to $50,000 for the testing system in the U.S. market. (Tests will not add appreciably to the typical cost of $12,000 to $15,000 for an IVF treatment.)
Availability: Now in the U.K., Australia, Japan, Ireland, and Greece; seeking FDA approval in the U.S.
Company: Molecular Biometrics
Other products in this section:
Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.Subscribe today
We won’t use CRISPR to make super-smart babies—but only because we can’t
Gene experts speculate that our worst gene-editing fears won’t come true because they are too complex for us to pull them off.
Electric nanoparticles can target and kill cancer cells by zapping them
Particles that produce electrical signals when bombarded with ultrasound could be a way to direct a cell-killing treatment directly to tumors.
Gene engineers make super-size plants that are 40% larger
Researchers hope to create a new “green revolution” by improving photosynthesis.